Off

docx

School

Walden University *

*We aren’t endorsed by this school

Course

6521

Subject

Medicine

Date

Apr 3, 2024

Type

docx

Pages

Uploaded by CaptainRainOryx29

1 Off-label Drug Use in Pediatrics Students Name Institution Instructors Name Date

2 Off-label Drug Use in Pediatrics Off-label drugs are those that have been licensed after extensive research demonstrating their safety and efficacy for a specific usage. Off-label drug use is the practice of prescription a medication for purposes other than those permitted by the FDA (Meng et al., 2022). In this scenario, the medicine is being utilized in a manner not specified on the package insert. This paper aims at describing off-label drug use in pediatrics. Circumstances when children should be prescribed drugs for off-label use One of the instances is when a child has a rare disease for which no FDA-approved drug or therapy choices exist. Another circumstance is where the standard treatments approved by the FDA fail to help the patient. For instance, if the approved medications have proven to be ineffective, or in a case where a child experiences severe side effects, the healthcare provider may decide to change the medication and shift to an off-label drug that has shown success in the past (Schrier et al., 2020). Strategies to make off-label use and drug dosage safer for children from infancy to adolescence Conducting research and labeling these drugs for pediatrics is one of the strategies. Research should be conducted focusing on the children population to have concrete evidence for the safety and efficacy of off-label drug use. These drugs should also be labeled correctly to provide information for the dosage of different age groups since pediatrics may not be given the same dose as children. The other strategy is collaboration and information sharing. Healthcare providers should collaborate with physicians who may help decision-making on the best off-label drug to use. Collaboration is associated with improved patient care (Schot et al., 2020).

3 Off-label Drugs that require Extra Care and Attention when used in Pediatrics Various drugs are used as off-label drugs in children and they require extra care. An example of drug that needs extra care is Albuterol. It is for two years and above patients but physicians may opt to use it for patients below two years in certain circumstances and under strict monitoring. In addition, some antidepressants such as serotonin reuptake inhibitors are used as off-label drugs. An example of an SSRI that is used as an off-label drug is Lexapro and it requires extra care since it may increase the risk of suicidal ideation especially in the early stages of treatment (Swathi, 2020). In conclusion, the use of off-label drugs must be taken with precaution. Healthcare providers ought to be careful when prescribing these drugs since they may lead to complications, especially in pediatrics. Conducting good research and labeling these drugs appropriately can assist in making these off-label drugs safer.

Your preview ends here

Eager to read complete document? Join bartleby learn and gain access to the full version

Access to all documents
Unlimited textbook solutions
24/7 expert homework help

4 References Meng, M., Lv, M., Wang, L., Yang, B., Jiao, P., Lei, W., ... & Li, Q. (2022). Off-label use of drugs in pediatrics: a scoping review. European Journal of Pediatrics , 181 (9), 3259- 3269. https://link.springer.com/article/10.1007/s00431-022-04515-7 Schot, E., Tummers, L., & Noordegraaf, M. (2020). Working on working together. A systematic review of how healthcare professionals contribute to interprofessional collaboration. Journal of Interprofessional Care , 34 (3), 332- 342. https://doi.org/10.1080/13561820.2019.1636007 Schrier, L., Hadjipanayis, A., Stiris, T., Ross-Russell, R. I., Valiulis, A., Turner, M. A., ... & van den Anker, J. (2020). Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European Society for Developmental Perinatal and Pediatric Pharmacology. European journal of pediatrics , 179 , 839- 847. https://link.springer.com/article/10.1007/s00431-019-03556-9 Swathi, D. N. (2020, June). Predicting drug side-effects from open source health forums using supervised classifier approach. In 2020 5th International Conference on Communication and Electronics Systems (ICCES) (pp. 796-800). IEEE. https://doi.org/10.1109/ICCES48766.2020.9138065

Off

Related Documents